Ono Pharmaceutical Co., Ltd.
4528.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥800,160 | ¥732,373 | ¥746,063 | ¥768,205 |
| - Cash | ¥182,060 | ¥138,991 | ¥204,567 | ¥160,982 |
| + Debt | ¥130,415 | ¥138,111 | ¥146,678 | ¥154,286 |
| Enterprise Value | ¥748,515 | ¥731,493 | ¥688,174 | ¥761,509 |
| Revenue | ¥129,600 | ¥127,536 | ¥112,309 | ¥134,223 |
| % Growth | 1.6% | 13.6% | -16.3% | – |
| Gross Profit | ¥94,637 | ¥90,523 | ¥67,072 | ¥88,387 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | ¥40,064 | ¥32,661 | -¥5,788 | ¥24,045 |
| % Margin | 30.9% | 25.6% | -5.2% | 17.9% |
| Net Income | ¥22,499 | ¥17,589 | -¥6,545 | ¥14,951 |
| % Margin | 17.4% | 13.8% | -5.8% | 11.1% |
| EPS Diluted | 47.89 | 37.58 | -13.93 | 31.81 |
| % Growth | 27.4% | 369.8% | -143.8% | – |
| Operating Cash Flow | ¥51,191 | ¥3,373 | ¥38,996 | ¥8,740 |
| Capital Expenditures | -¥1,660 | -¥2,250 | -¥1,421 | -¥1,204 |
| Free Cash Flow | ¥49,531 | ¥1,123 | ¥37,575 | ¥7,536 |